Skip to Main Content

Paper Details

Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.
Clin Cancer Res
1
2023
Author NameAffiliation
Neil E FleshnerPrincess Margaret Cancer Centre, University Health Network
Joseph L ChinWestern University
Eric WinquistSchulich School of Medicine and Dentistry, Western University
Theodorus H van der KwastUniversity of Toronto
Katherine LajkoszUniversity of Toronto
Madeleine MoussaWestern University
Antonio FinelliPrincess Margaret Cancer Centre, University Health Network
Girish S KulkarniPrincess Margaret Cancer Centre, University Health Network
Alexandre R Zlotta
Anthony M JoshuaKinghorn Cancer Centre, St Vincent's Hospital, Garvan Institute of Medical Research
  • 1 - 10

Datasets

Release 1.2